Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.

Erenay FS, Alagoz O, Banerjee R, Said A, Cima RR.

Cancer. 2016 Aug 15;122(16):2560-70. doi: 10.1002/cncr.30091.

PMID:
27248907
2.

Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline.

Spada C, Stoker J, Alarcon O, Barbaro F, Bellini D, Bretthauer M, De Haan MC, Dumonceau JM, Ferlitsch M, Halligan S, Helbren E, Hellstrom M, Kuipers EJ, Lefere P, Mang T, Neri E, Petruzziello L, Plumb A, Regge D, Taylor SA, Hassan C, Laghi A.

Eur Radiol. 2015 Feb;25(2):331-45. doi: 10.1007/s00330-014-3435-z. No abstract available.

3.

Review of economic evidence in the prevention and early detection of colorectal cancer.

Jeong KE, Cairns JA.

Health Econ Rev. 2013 Sep 12;3(1):20. doi: 10.1186/2191-1991-3-20.

4.

A multi-centre randomised double-blind placebo-controlled trial to evaluate the value of a single bolus intravenous alfentanil in CT colonography.

Boellaard TN, van der Paardt MP, Hollmann MW, Eberl S, Peringa J, Schouten LJ, Kavaliauskiene G, Runge JH, Tielbeek JA, Stoker J.

BMC Gastroenterol. 2013 May 25;13:94. doi: 10.1186/1471-230X-13-94.

5.

Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.

Behl AS, Goddard KA, Flottemesch TJ, Veenstra D, Meenan RT, Lin JS, Maciosek MV.

J Natl Cancer Inst. 2012 Dec 5;104(23):1785-95. doi: 10.1093/jnci/djs433.

6.

Can radiographers be trained to triage CT colonography for extracolonic findings?

Boellaard TN, Nio CY, Bossuyt PM, Bipat S, Stoker J.

Eur Radiol. 2012 Dec;22(12):2780-9. doi: 10.1007/s00330-012-2541-z.

7.

Does CT colonography have a role for population-based colorectal cancer screening?

de Haan MC, Halligan S, Stoker J.

Eur Radiol. 2012 Jul;22(7):1495-503. doi: 10.1007/s00330-012-2449-7.

8.

A randomized double-blind placebo-controlled trial to evaluate the value of a single bolus intravenous alfentanil in CT colonography.

Boellaard TN, van der Paardt MP, Eberl S, Hollmann MW, Stoker J.

BMC Gastroenterol. 2011 Nov 23;11:128. doi: 10.1186/1471-230X-11-128.

9.

Clarifying differences in natural history between models of screening: the case of colorectal cancer.

van Ballegooijen M, Rutter CM, Knudsen AB, Zauber AG, Savarino JE, Lansdorp-Vogelaar I, Boer R, Feuer EJ, Habbema JD, Kuntz KM.

Med Decis Making. 2011 Jul-Aug;31(4):540-9. doi: 10.1177/0272989X11408915.

10.

Cost-effectiveness of colorectal cancer screening.

Lansdorp-Vogelaar I, Knudsen AB, Brenner H.

Epidemiol Rev. 2011;33:88-100. doi: 10.1093/epirev/mxr004. Review.

11.

Computer disease simulation models: integrating evidence for health policy.

Rutter CM, Knudsen AB, Pandharipande PV.

Acad Radiol. 2011 Sep;18(9):1077-86. doi: 10.1016/j.acra.2011.02.004. Review.

12.

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening.

Wever EM, Draisma G, Heijnsdijk EA, de Koning HJ.

Med Decis Making. 2011 Jul-Aug;31(4):550-8. doi: 10.1177/0272989X10396717.

13.

Are physicians' recommendations for colorectal cancer screening guideline-consistent?

Yabroff KR, Klabunde CN, Yuan G, McNeel TS, Brown ML, Casciotti D, Buckman DW, Taplin S.

J Gen Intern Med. 2011 Feb;26(2):177-84. doi: 10.1007/s11606-010-1516-5.

14.

Cost-effectiveness of colonoscopy.

Zauber AG.

Gastrointest Endosc Clin N Am. 2010 Oct;20(4):751-70. doi: 10.1016/j.giec.2010.07.008. Review.

15.

Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.

Ladabaum U, Ferrandez A, Lanas A.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2765-76. doi: 10.1158/1055-9965.EPI-10-0530.

16.

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.

Knudsen AB, Lansdorp-Vogelaar I, Rutter CM, Savarino JE, van Ballegooijen M, Kuntz KM, Zauber AG.

J Natl Cancer Inst. 2010 Aug 18;102(16):1238-52. doi: 10.1093/jnci/djq242.

17.

Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial.

de Wijkerslooth TR, de Haan MC, Stoop EM, Deutekom M, Fockens P, Bossuyt PM, Thomeer M, van Ballegooijen M, Essink-Bot ML, van Leerdam ME, Kuipers EJ, Dekker E, Stoker J.

BMC Gastroenterol. 2010 May 19;10:47. doi: 10.1186/1471-230X-10-47.

18.

Computed tomographic colonography: hope or hype?

Lin OS.

World J Gastroenterol. 2010 Feb 28;16(8):915-20. Review.

19.

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA.

Cancer. 2010 Feb 1;116(3):544-73. doi: 10.1002/cncr.24760.

Items per page

Supplemental Content

Support Center